SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 299,677.94 |
Enterprise Value ($M) | 333,909.94 |
Book Value ($M) | 77,463.00 |
Book Value / Share | 13.81 |
Price / Book | 3.87 |
NCAV ($M) | -46,736.00 |
NCAV / Share | -8.33 |
Price / NCAV | -6.41 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | 0.21 |
Return on Assets (ROA) | 0.16 |
Return on Equity (ROE) | 0.36 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 1.13 |
Current Ratio | 1.39 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 54,420.00 |
Assets | 183,841.00 |
Liabilities | 101,156.00 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 81,288.00 |
Operating Income | 26,845.00 |
Net Income | 21,979.00 |
Earnings Per Share Diluted | n/a |
Earnings Per Share Basic | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 32,580.00 |
Cash from Investing | -22,546.00 |
Cash from Financing | -9,816.00 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | State Street Corp | 5.09 | 2.12 | |
13G/A | Vanguard Group Inc | 8.29 | 3.87 | |
13G/A | BlackRock Inc. | 7.30 | 3.28 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
2,016,152 | 20,809,432 | 9.69 | |
2,311,399 | 23,824,852 | 9.70 | |
1,880,829 | 19,531,215 | 9.63 | |
3,220,411 | 26,702,234 | 12.06 | |
(click for more detail) |
|||
(click for list of largest short owners) |
Similar Companies | |
---|---|
NVS – Novartis AG | OGN – Organon & Co. |
PBH – Prestige Brands Holdings, Inc. | PRGO – Perrigo Company PLC |
QGEN – QIAGEN N.V. |
Financial data and stock pages provided by
Fintel.io